The European session opens with expectations regarding the results of peace meetings and the publication of the FED minutes. The market reaction is moderate.
DE40: -0.17%
FRA40: +0.36%
UK100: -0.14%
EU50: +0.13%
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile appThere are no significant company results or macroeconomic data in the European market, so investors are waiting for the next impulse, primarily from the FED. This Wednesday, the so-called FOMC Minutes will be published, which will show the record of discussions during the last meeting. The Minutes may reveal, to a greater extent than the statement, what other members, besides Jerome Powell, think about the prospects for interest rates. Of course, from the Fed's perspective, the more important event will be Friday's economic symposium in Jackson Hole, where the main event will be speeches by Powell and other Fed members.
Leaders of selected European countries and NATO met yesterday with Donald Trump to continue peace negotiations. The USA declares its willingness to provide guarantees after the end of the war, while EU/NATO leaders are advocating for further sanctions.
Currently, the EU economy and market are under pressure from US tariffs, competition from China, threats from Russia, and internal problems, including low growth and debt. Considering valuations, at the moment, investors seem to believe that the European community will overcome most of these issues, but the question remains whether these hopes will prove justified.
DE40 (D1)
The German index is currently in the middle of a consolidation channel, in an upward trend. The market defended the trend line at the EMA100 average, which serves as strong support in case of declines. The next resistance to overcome on the index is the all-time high from last month at the level of 24757.
Company news:
Hope for the end of the war is sinking defense company stocks - The possibility of ending hostilities and reducing the demand for weapons and ammunition negatively impacts the stocks of European defense industry giants. Rheinmetall (RHM.DE) is down over 3%. Dassault (AM.FR) is losing over 2%. BAE (BA.UK) is also down over 2%.
Stratec (SBS.DE) - The medical-diagnostic company published its report for the first half of 2025, which the market received very positively. Sales are increasing, and the margin remains stable, resulting in a gap-up opening, and currently, the price increase is over 3%.
Merck KGaA (MKR.DE) - Another investment bank has downgraded the rating for the biotechnology company's stock. Valuations are reacting with a decline of about 1%
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
